Month: December 2021

A computer analysis of hundreds of thousands of secure email messages between doctors and patients found that most doctors use language that is too complex for their patients to understand. The study also uncovered strategies some doctors use to overcome communication barriers. Experts on health literacy, as well as leading health care organizations, have advised
0 Comments
Becoming a new parent can feel overwhelming. We share seven simple tips to help you create a sustainable self-care routine while caring for a new baby No matter how much you love them, parenthood can feel pretty overwhelming. Having a baby naturally leads to a change in how we prioritise ourselves and, well, everything in
0 Comments
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) recommended marketing authorization for anifrolumab (Saphnelo) as an add-on treatment for adults with moderate to severe, active autoantibody-positive systemic lupus erythematosus (SLE), despite standard therapy, according to an announcement on Dec. 16. Anifrolumab, a monoclonal antibody that binds to subunit 1 of the
0 Comments
Margin marking before endoscopic mucosal resection (EMR) of large colorectal polyps cut the risk of recurrence by 80% when compared with traditional EMR, new data suggest. A team of researchers, led by Dennis Yang, MD, with the Center for Interventional Endoscopy at AdventHealth in Orlando, Florida, compared polyp recurrence after patients received EMR with margin
0 Comments
Theranos founder Elizabeth Holmes arrives to attend her fraud trial at federal court in San Jose, California, December 17, 2021. Peter DaSilva | Reuters SAN JOSE, Calif. — The 12 jurors who will decide the fate of Theranos founder Elizabeth Holmes are left to consider the testimony from 31 witnesses over three months as they
0 Comments
A Day in the Life of…Dr. Alexander MarmureanuThoracic and Cardiovascular Surgeon In this interview, we spoke to Dr. Alexander Marmureanu, a thoracic and cardiovascular surgeon, about his day-to-day role and responsibilities as well as his career highlights. What inspired your career into thoracic and cardiovascular surgery? It’s a very good question, but it started a
0 Comments
Researchers at Houston Methodist may have hit a breakthrough recently as they discovered a combination treatment that significantly improves the chances that a patient’s drug-resistant triple-negative breast cancer will respond positively to the treatment. The research team, led by Dr. Jenny Chang, director of the Cancer Center and Emily Herrmann Presidential Distinguished Chair in Cancer
0 Comments
A medication typically used for treating diabetes, glucagon-like peptide-1 receptor agonists (GLP-1 RA), could also be used to prevent cardiovascular disease and major cardiovascular events, but a new study showed inequities in its use based on race, ethnicity, and socioeconomic status. Looking at four years of data, researchers from the Perelman School of Medicine at
0 Comments
Prompt action aids recovery – so here’s how to spot the early signs of this distressing condition, and where to go for help Around 80% of people who experience psychosis for the first time are aged between 16 and 30 years old. These years are pivotal for a lot of us and, although psychotic symptoms
0 Comments
Two cancer drugs and one drug to treat sickle cell disease will likely reach the European market soon, following approval recommendations from a European Medicines Agency (EMA) panel. The drugs are enfortumab vedotin (Padcev, Astellas/Seagen) for urothelial cancer, tepotinib (Tepmetko, Merck) for non-small cell lung cancer (NSCLC), and voxelotor (Oxbryta, Global Blood Therapeutics) for sickle
0 Comments
The US Food and Drug Administration (FDA) has approved efgartigimod (Vyvgart, argenx), a first-in-class, targeted therapy for adults with generalized myasthenia gravis (gMG) who test positive for the antiacetylcholine receptor (AChR) antibody. “There are significant unmet medical needs for people living with myasthenia gravis, as with many other rare diseases,” Billy Dunn, MD, director, Office
0 Comments
A collaborative study from the Center for Injury Research and Prevention (CIRP) and the Center for Autism Research (CAR) at Children’s Hospital of Philadelphia (CHOP) found that only 8% of pediatric healthcare and behavioral service providers feel prepared to assess whether their autistic patients are ready to drive. These findings, recently published in the Journal
0 Comments
For cancer patients and families who are in current treatment, holidays can be a bit tricky. We may not have the energy for large gatherings. Our appetites and treatment sensitivities may suggest a small and VERY downsized day…even a day that is very private. People can get really stressed out around the holidays. We can
0 Comments
On the night of December 10th, and continuing on into December 11th, a series of unprecedented weather events struck in six U.S. states. At least 30 tornadoes touched down in various parts of Arkansas, Illinois, Kentucky, Missouri, Mississippi, and Tennessee, leaving unspeakable devastation in their wake. Kentucky was hit especially hard; one of the tornadoes
0 Comments
Posted on December 17, 2021 by Admin For many, winter is the happiest time of the year. Families gather for the holidays and friends celebrate as they usher in another new year. Winter can also be a difficult time for older adults. The onset of cold weather can create hazardous conditions outside, and people often prefer to stay home when it’s
0 Comments
Recent studies indicated that the effectiveness of the coronavirus disease 2019 (COVID-19) messenger RNA (mRNA) vaccines especially the mRNA-1273 (Moderna) and BNT162b2 (Pfizer-BioNTech) vaccines, against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was high for US veterans who were vaccinated in January and February of 2021. However, the emergence of the Delta variant of concern
0 Comments
Black women with metastatic triple-negative breast cancer (mTNBC) have outcomes in response to the antibody–drug conjugate sacituzumab govitecan (SG) (Trodelvy, Gilead) comparable to those of the overall patient population, with the drug showing similar efficacy and safety, shows a prespecified analysis of ASCENT. A heterogenous disease with few treatment options and poor outcomes, mTNBC has
0 Comments
Ovarian, bowel and non-Hodgkin’s lymphoma treatments approved for NHS use in Scotland Three new treatment options will be made available for patients in Scotland living with advanced ovarian cancer, bowel cancer and a rare form of non-Hodgkin’s lymphoma. The latest batch of drug decisions from The Scottish Medicines Consortium (SMC) includes the approval of olaparib,
0 Comments
 Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. The number of reported circulating vaccine-derived poliovirus (cVDPV) outbreaks more than tripled to 29 since January 2017. Most (86%) of these outbreaks were caused by cVDPV2 (circulating VDPV type 2 poliovirus, which originated with the vaccine), and most occurred in Africa, according
0 Comments
A healthcare worker holds a dose of the Johnson & Johnson vaccine. Phill Magakoe | AFP | Getty Images An advisory panel for the Centers for Disease Control and Prevention on Thursday recommended Pfizer and Moderna‘s vaccines over Johnson & Johnson‘s shot for adults 18 and over, after finding dozens of people developed a rare
0 Comments
The holiday season is in full swing. You may have already picked up the perfect gifts for the healthcare workers in your life. But if you have young children on your list, that likely means you’re in the market for some toys. Luckily, there are plenty of fun and inventive options out there, especially if
0 Comments
Mutations in a histone regulator protein are linked to both a rare neurodevelopmental disorder and to some cancers, according to a study published in the journal Genes and Development. Marc Morgan, DPhil, research assistant professor of Biochemistry and Molecular Genetics, was lead author of the study published in the journal Genes and Development. The protein,
0 Comments